眼部给药系统的进展
Advances in Ocular Drug Delivery Systems.
作者信息
Silva-Cunha Armando
机构信息
Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
出版信息
Pharmaceutics. 2021 Sep 1;13(9):1383. doi: 10.3390/pharmaceutics13091383.
Abstract
There have been major advances in the treatment of eye diseases over the last years [...].
摘要
在过去几年里，眼科疾病的治疗取得了重大进展[……]。
相似文献
1
Advances in Ocular Drug Delivery Systems.眼部给药系统的进展
Pharmaceutics. 2021 Sep 1;13(9):1383. doi: 10.3390/pharmaceutics13091383.
2
Advances and limitations of drug delivery systems formulated as eye drops.滴眼剂给药系统的进展与局限。
J Control Release. 2020 May 10;321:1-22. doi: 10.1016/j.jconrel.2020.01.057. Epub 2020 Feb 3.
3
Advances in ocular drug delivery.眼部药物输送的新进展。
Curr Eye Res. 2012 May;37(5):345-56. doi: 10.3109/02713683.2011.652286.
4
Recent Advances in Topical Ocular Drug Delivery.眼部局部给药的最新进展
J Ocul Pharmacol Ther. 2016 Mar;32(2):67-82. doi: 10.1089/jop.2015.0047. Epub 2015 Dec 14.
5
Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.利用分子印迹软性隐形眼镜开发眼部给药系统。
Drug Dev Ind Pharm. 2015 May;41(5):703-13. doi: 10.3109/03639045.2014.948451. Epub 2014 Aug 12.
6
Recent advances in ocular drug delivery.眼部药物输送的最新进展。
Drug Dev Ind Pharm. 2013 Nov;39(11):1599-617. doi: 10.3109/03639045.2012.736515. Epub 2012 Nov 16.
7
Recent advances in drug delivery systems for treating ocular complications of systemic diseases.用于治疗全身性疾病眼部并发症的药物递送系统的最新进展。
Curr Opin Ophthalmol. 2009 Nov;20(6):511-9. doi: 10.1097/ICU.0b013e328330ccb9.
8
Recent advances in topical nano drug-delivery systems for the anterior ocular segment.眼前节局部纳米药物递送系统的最新进展
Ther Deliv. 2018 Feb;9(2):137-153. doi: 10.4155/tde-2017-0088.
9
Ocular drug delivery.眼部药物递送
Expert Opin Drug Deliv. 2006 Mar;3(2):275-87. doi: 10.1517/17425247.3.2.275.
10
Episcleral, intrascleral, and suprachoroidal routes of ocular drug delivery - recent research advances and patents.眼部药物递送的巩膜上、巩膜内和脉络膜上途径——最新研究进展与专利
Recent Pat Drug Deliv Formul. 2014;8(2):81-91. doi: 10.2174/187221130802140707093509.
本文引用的文献
1
Artificial Protein Coronas Enable Controlled Interaction with Corneal Epithelial Cells: New Opportunities for Ocular Drug Delivery.人工蛋白质冠层实现与角膜上皮细胞的可控相互作用：眼部药物递送的新机遇
Pharmaceutics. 2021 Jun 12;13(6):867. doi: 10.3390/pharmaceutics13060867.
2
Neuroprotective Effect of siRNA Entrapped in Hyaluronic Acid-Coated Lipoplexes by Intravitreal Administration.玻璃体内注射透明质酸包被的脂质复合物包裹的小干扰RNA的神经保护作用
Pharmaceutics. 2021 Jun 8;13(6):845. doi: 10.3390/pharmaceutics13060845.
3
Pullulan Based Bioconjugates for Ocular Dexamethasone Delivery.用于眼部地塞米松递送的基于普鲁兰多糖的生物共轭物
Pharmaceutics. 2021 May 26;13(6):791. doi: 10.3390/pharmaceutics13060791.
4
A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability.一种用于玻璃体内给药的新型贝伐单抗载体：聚焦稳定性。
Pharmaceutics. 2021 Apr 15;13(4):560. doi: 10.3390/pharmaceutics13040560.
5
Intravitreal Polymeric Nanocarriers with Long Ocular Retention and Targeted Delivery to the Retina and Optic Nerve Head Region.具有长时间眼内滞留并靶向递送至视网膜和视神经乳头区域的玻璃体内聚合物纳米载体。
Pharmaceutics. 2021 Mar 26;13(4):445. doi: 10.3390/pharmaceutics13040445.
6
Formulation Considerations for the Management of Dry Eye Disease.干眼症管理的制剂考量
Pharmaceutics. 2021 Feb 3;13(2):207. doi: 10.3390/pharmaceutics13020207.
7
Self-Assembling Tacrolimus Nanomicelles for Retinal Drug Delivery.用于视网膜药物递送的自组装他克莫司纳米胶束
Pharmaceutics. 2020 Nov 10;12(11):1072. doi: 10.3390/pharmaceutics12111072.
Zotero 插件